𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cross-sectional tests of the CAPM and Fama–French three-factor model

✍ Scribed by Robert R. Grauer; Johannus A. Janmaat

Book ID
116615467
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
769 KB
Volume
34
Category
Article
ISSN
0378-4266

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Drug development costs when financial ri
Drug development costs when financial risk is measured using the Fama–French three-factor model
✍ John A. Vernon; Joseph H. Golec; Joseph A. Dimasi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

## Abstract In a widely cited article, DiMasi, Hansen, and Grabowski (2003) estimate the average pre‐tax cost of bringing a new molecular entity to market. Their base case estimate, excluding post‐marketing studies, was $802 million (in $US 2000). Strikingly, almost half of this cost (or $399 milli

The performance of heteroskedasticity an
The performance of heteroskedasticity and autocorrelation robust tests: a Monte Carlo study with an application to the three-factor Fama–French asset-pricing model
✍ Surajit Ray; N. E. Savin 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 1 views

## Abstract This paper illustrates the pitfalls of the conventional heteroskedasticity and autocorrelation robust (HAR) Wald test and the advantages of new HAR tests developed by Kiefer and Vogelsang in 2005 and by Phillips, Sun and Jin in 2003 and 2006. The illustrations use the 1993 Fama–French t